Orion Pharma Limited

DSE:ORIONPHARM Stok Raporu

Piyasa değeri: ৳9.7b

Orion Pharma Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Orion Pharma's earnings have been declining at an average annual rate of -6.1%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been growing at an average rate of 12.7% per year. Orion Pharma's return on equity is 1.9%, and it has net margins of 4%.

Anahtar bilgiler

-6.1%

Kazanç büyüme oranı

-6.1%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi11.0%
Gelir büyüme oranı12.7%
Özkaynak getirisi1.9%
Net Marj4.0%
Son Kazanç Güncellemesi31 Mar 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Orion Pharma nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

DSE:ORIONPHARM Gelir, gider ve kazançlar (BDT Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Mar 2411,4964551,5040
31 Dec 2311,7594801,4820
30 Sep 2313,6226481,3690
30 Jun 2313,9276411,2820
31 Mar 2316,7937001,3150
31 Dec 2215,6338211,3570
30 Sep 2212,3899451,3100
30 Jun 229,6628461,2940
31 Mar 226,1509611,2290
31 Dec 217,4519381,1700
30 Sep 219,0918181,1630
30 Jun 2110,8339391,1380
31 Mar 2110,1937181,1380
31 Dec 209,2086391,0660
30 Sep 208,3505831,0370
30 Jun 207,6486661,0260
31 Mar 207,2108231,0210
31 Dec 196,9889019860
30 Sep 197,3529289780
30 Jun 198,7058829570
31 Mar 199,4858591,0150
31 Dec 1810,8027989660
30 Sep 1811,1457728790
30 Jun 1810,4238028550
31 Mar 1810,3277347350
31 Dec 1710,0857058310
30 Sep 179,7737797580
30 Jun 179,5347947760
31 Mar 179,6851,0447650
31 Dec 169,5699886870
30 Sep 169,7229854430
30 Jun 169,8678826580
30 Sep 1510,4177781,4910
30 Jun 1510,5907871,1150
31 Mar 1510,9389448690
31 Dec 1410,7079946860

Kaliteli Kazançlar: ORIONPHARM has high quality earnings.

Büyüyen Kar Marjı: ORIONPHARM's current net profit margins (4%) are lower than last year (4.2%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: ORIONPHARM's earnings have declined by 6.1% per year over the past 5 years.

Büyüme Hızlandırma: ORIONPHARM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: ORIONPHARM had negative earnings growth (-34.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-2.8%).


Özkaynak Getirisi

Yüksek ROE: ORIONPHARM's Return on Equity (1.9%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin